Range Cancer Therapeutics ETF (CNCR)

Assets	$6.95M
Expense Ratio	0.79%
PE Ratio	n/a
Shares Out	780,814
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	3,077
Open	9.41
Previous Close	n/a
Day's Range	9.02 - 9.41
52-Week Low	7.88
52-Week High	16.27
Beta	0.95
Holdings	2
Inception Date	Oct 13, 2015

About CNCR

The Range Cancer Therapeutics ETF (CNCR) is an exchange-traded fund that is based on the Range Oncology Therapeutics index. The fund tracks an equal-weighted index of companies currently developing oncology drugs or selling cancer therapeutic products. CNCR was launched on Oct 13, 2015 and is issued by Range.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NASDAQ
• Ticker Symbol: CNCR
• ETF Provider: Range
• Index Tracked: Range Oncology Therapeutics Index

Top Holdings

Name	Symbol	Weight
US DOLLARS	n/a	99.94%
DEPOSITS WITH BROKER FOR SHORT POSITIONS	n/a	0.06%

Performance

CNCR had a total return of -38.26% in the past year, including dividends. Since the fund's inception, the average annual return has been -9.43%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

May 29, 2025

Data Sources Report a data error